OM Pharma SA

Quick facts

Marketed products

• OM-85 · Immunology

Phase 3 pipeline

• Broncho-Vaxom · Immunology / Respiratory
  Broncho-Vaxom is an oral immunostimulant that enhances innate and adaptive immune responses to prevent recurrent respiratory tract infections.

Phase 1 pipeline

• OM-85-IN

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• OM Pharma SA portfolio CI brief
• OM Pharma SA pipeline updates RSS